Vicks Dayquil And Vicks Nyquil Kit
NDC 84126-361

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 84126-361?
  5. Vicks Dayquil And Vicks Nyquil Intense Flu Rapid Release Liquicaps Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes

Product Information

Vicks Dayquil And Vicks Nyquil (acetaminophen, doxylamine succinate, dextromethorphan hbr) is a OTC MONOGRAPH DRUG-approved product labeled by The Procter & Gamble Manufacturing Company. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a orange kit. This product entry covers the primary NDC 84126-361 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
84126-361
Proprietary Name:
Vicks Dayquil And Vicks Nyquil Intense Flu Rapid Release Liquicaps
Non-Proprietary Name: [1]
Acetaminophen, Doxylamine Succinate, Dextromethorphan Hbr
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Kit - A packaged collection of related material.

Labeler & Regulatory Data

Labeler Name: [5]
The Procter & Gamble Manufacturing Company
Labeler Code:
84126
Product Label ID:
bfff40f6-8586-4e4b-8db1-d96ba4819a09
FDA Application Number: [6]
M012
Marketing Category: [8]
OTC MONOGRAPH DRUG

Marketing Timeline

Start Marketing Date: [9]
05-18-2026
Listing Expiration Date: [11]
12-31-2027
Exclude Flag: [12]
N

Product Characteristics

Color(s):
ORANGE (C48331)
GREEN (C48329)
Shape:
OVAL (C48345)
Size(s):
21 MM
Imprint(s):
DQS
NQS
Score:
1

Code Structure Chart

Product Details

What is NDC 84126-361?

The NDC code 84126-361 is assigned by the FDA to the product Vicks Dayquil And Vicks Nyquil Intense Flu Rapid Release Liquicaps. It is commonly known by its generic name, acetaminophen, doxylamine succinate, dextromethorphan hbr. This pharmaceutical product is labeled by The Procter & Gamble Manufacturing Company and is currently categorized as listed product. The medication is a kit. In terms of distribution, this product is available in 2 different package configurations. The associated package NDC(s) include: 84126-361-12, 84126-361-48. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Take only as directeddo not exceed 6 LiquiCaps per 24 hrsadults & children 12 yrs & over2 LiquiCaps with water every 6 hrschildren 4 to under 12 yrsask a doctorchildren under 4 yrsdo not use take only as directeddo not exceed 6 LiquiCaps per 24 hrsadults & children 12 yrs & over2 LiquiCaps with water every 6 hrschildren 4 to under 12 yrsask a doctorchildren under 4 yrsdo not use

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".